发明名称 |
TREATMENT OF B CELL MALIGNANCIES USING COMBINATION OF B CELL DEPLETING ANTIBODY AND IMMUNE MODULATING ANTIBODY RELATED APPLICATIONS |
摘要 |
A combination antibody therapy for treating B cell malignancies using an immunoregulatory antibody, especially an anti-B7, anti-CD23, or anti-CD40L antibody and a B cell depleting antibody, especially anti-CD19, anti-CD20, anti-CD22 or anti-CD37 antibody is provided. Preferably, the combination therapy will comprise anti-B7 and anti-CD20 antibody administration.
|
申请公布号 |
WO0204021(A9) |
申请公布日期 |
2003.01.16 |
申请号 |
WO2001US15677 |
申请日期 |
2001.05.16 |
申请人 |
IDEC PHARMACEUTICALS CORPORATION |
发明人 |
HANNA, NABIL;HARIHARAN, KANDASAMY |
分类号 |
A61K45/00;A61K;A61K31/166;A61K31/196;A61K31/282;A61K31/475;A61K31/519;A61K31/573;A61K31/675;A61K31/704;A61K31/7068;A61K38/46;A61K39/395;A61K51/00;A61P35/00;A61P35/02;A61P43/00;C07K;C07K16/28;(IPC1-7):A61K39/395;C07K16/32 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|